In this study, 21 patients with unilateral APU (10 male, 11 female) and 21 age-matched NC were included. The mean age was 10.9 ± 2.7 years in the APU group and 11.0 ± 2.5 years in the NC group. Of the 21 patients, 17 were idiopathic and 4 were JIA-associated uveitis. All included OCT and OCTA scans had complete retinal and choroidal structures and correct automatic segmentations obviating the need for additional manual adjustments. For affected eyes, the mean duration of remission was 10.47 ± 6.69 (range, 3–22) months. The mean BCVA was 0.06 ± 0.11 log MAR in the affected group, -0.01 ± 0.04 logMAR in the fellow eye group, and 0.00 ± 0.06 logMAR in the NC group (all p values > 0.05). The demographic information is presented in Table 1.
Table 1
The demographics and clinical characteristic of the participants.
|
APU
|
Fellow
|
NC
|
p value
|
p value
|
p value
|
Characteristic
|
(N=21)
|
(N=21)
|
(N=21)
|
(APU vs. fellow)
|
(APU vs. NC)
|
(Fellow vs. NC)
|
Age, y mean (SD)
|
10.9 (2.7)
|
10.9 (2.7)
|
11.0 (2.5)
|
1.000
|
0.900
|
0.900
|
Gender,female (N) (%)
|
11 (52.4)
|
11 (52.4)
|
14 (66.7)
|
1.000
|
0.351
|
0.351
|
logMAR BCVA
|
0.06±0.11
|
-0.01±0.04
|
0.00±0.06
|
0.114
|
0.106
|
0.115
|
Side, right (N) (%)
|
13 (61.9)
|
8 (38.1)
|
11 (52.4)
|
0.129
|
0.538
|
0.358
|
Remission time (months)
|
10.47±6.69
|
-
|
-
|
-
|
-
|
-
|
SD Standard deviation, NC Normal control, logMAR Logarithm of the minimal angle of resolution, BCVA Best-corrected visual acuity.
*Statistically significant p value.
|
Retinal Analysis
SCP VD and DCP VD were significantly decreased in all eyes in affected APU eyes compared with NCs (both p <.001). However, the CMT and FAZ were not statistically different between APU and NC groups (p = 0.880 and p = 0.297). All fellow eyes of APU patients also had a significantly lower SCP VD and DCP VD (p =.021 and p <.001) compared with the NC group, however, the decrease of SCP VD was less than that in the affected eye. The CMT had a significant decrease in the fellow eye compared to the NC group (p = 0.037). The FAZ did not differ significantly between the fellow eye group and NC group (p = 0.651). (Table 2)
Choroidal Analysis
The SFCT of the affected APU eyes was significantly thicker than that of the NC eyes but was not significantly different from the fellow eyes (306.9±49.0 μm vs 254.1±48.7 μm and 279.6±56.1 μm, p = 0.003and p = 0.101, respectively). The mean CFD-1.00, 1.50, and 3.00 of the affected eyes were 66.0%, 66.2%, and 67.4%, respectively, which were significantly lower than those of the fellow eyes (p = 0.012, p = 0.015, and p = 0.036, respectively) and the NC eyes (p = 0.003, p = 0.006, and p = 0.010, respectively). However, there was no significant difference between the fellow eye group and the NC group. (Table 2)
Table 2
Comparisons of OCTA and OCT parameters among affected APU eyes, the fellow eyes and NCs.
|
APU
|
fellow
|
NC
|
p value
|
p value
|
p value
|
Parameters
|
(N=21)
|
(N=21)
|
(N=21)
|
(APU vs. fellow)
|
(APU vs. NC)
|
(Fellow vs. NC)
|
CMT (μm)
|
212.1±21.7
|
205.9±18.3
|
212.5±10.3
|
0.320
|
0.880
|
0.037*
|
SCP VD (%)
|
44.4±4.9
|
47.0±4.8
|
49.7±1.9
|
0.072
|
<0.001*
|
0.021*
|
DCP VD (%)
|
47.9±4.4
|
52.8±3.2
|
56.4±2.3
|
<0.001*
|
<0.001*
|
<0.001*
|
FAZ area, mm2
|
0.282±0.133
|
0.280±0.122
|
0.261±0.067
|
0.953
|
0.297
|
0.651
|
SFCT (μm)
|
306.9±49.0
|
279.6±56.1
|
254.1±48.7
|
0.101
|
0.003*
|
0.199
|
CDF1.0 (%)
|
0.660±0.048
|
0.696±0.039
|
0.703±0.030
|
0.012*
|
0.003*
|
0.763
|
CDF1.5 (%)
|
0.662±0.050
|
0.698±0.040
|
0.705±0.022
|
0.015*
|
0.006*
|
0.744
|
CDF3.0 (%)
|
0.674±0.042
|
0.699±0.031
|
0.708±0.021
|
0.036*
|
0.010*
|
0.513
|
NC Normal control, CMT Central macular thickness, SCP Superficial capillary plexus, DCP Deep capillary plexus, VD Vascular density, FAZ Foveal avascular zone, SFCT Subfoveal choroidal thickness, CFD Choriocapillaris flow density.
*Statistically significant p value.
|
Correlation Analysis
Univariate analysis (Table 3) revealed that FAZ and SFCT were both negatively correlated with CFD1.0, CFD1.5, CFD3.0 (p = .001, p < .001, p = .007; p = .004, p = .004, p = .004, respectively). The DCP VD was positively correlated with CFD1.0, CFD1.5, CFD3.0 (p = .013; p = .023; p = .021, respectively). According to multiple linear regression, CFD1.0, CFD1.5, CFD3.0 were statistically correlated with FAZ (p = 0.015, p = 0.009, and p = 0.010, respectively), CMT (p = 0.026, p = 0.002, and p = 0.028, respectively). CFD1.0, CFD1.5 were statistically correlated with DCP VD (p = 0.047 and p = 0.045, respectively). (Table 4)
Table 3
Univariate analysis of potential correlation factors with CFD-1.00, CFD-1.50, and CFD-3.00 as dependent variable.
|
SCP VD
|
|
DCP VD
|
|
CFD1.0
|
|
CFD1.5
|
|
CFD3.0
|
|
Characteristic
|
Correlation Coefficient
|
p valuea
|
Correlation Coefficient
|
p valuea
|
Correlation Coefficient
|
p valuea
|
Correlation Coefficient
|
p valuea
|
Correlation Coefficient
|
p valuea
|
Age
|
-0.109
|
0.491
|
0.113
|
0.476
|
0.046
|
0.770
|
0.032
|
0.839
|
0.125
|
0.431
|
Gender,female
|
-0.169
|
0.284
|
-0.061
|
0.701
|
-0.256
|
0.102
|
-0.181
|
0.251
|
-0.173
|
0.273
|
log MAR BCVA
|
-0.209
|
0.184
|
-0.279
|
0.073
|
-0.256
|
0.102
|
-0.278
|
0.066
|
-0.181
|
0.251
|
FAZ
|
0.145
|
0.361
|
-0.158
|
0.318
|
-0.477
|
0.001*
|
-0.411
|
0.007*
|
-0.439
|
0.004*
|
CMT
|
-0.091
|
0.565
|
-0.021
|
0.895
|
-0.160
|
0.311
|
-0.263
|
0.093
|
-0.177
|
0.263
|
SFCT
|
0.121
|
0.445
|
-0.397
|
0.009*
|
-0.514
|
<0.001*
|
-0.432
|
0.004*
|
-0.431
|
0.004*
|
SCP VD
|
1.000
|
——
|
0.081
|
0.611
|
0.159
|
0.314
|
0.213
|
0.175
|
0.084
|
0.559
|
DCP VD
|
0.174
|
0.271
|
1.000
|
——
|
0.382
|
0.013*
|
0.349
|
0.023*
|
0.355
|
0.021*
|
logMAR Logarithm of the minimal angle of resolution, BCVA Best-corrected visual acuity, FAZ Foveal avascular zone, CMT Central macular thickness, SFCT Subfoveal choroidal thickness, SCP Superficial capillary plexus, DCP Deep capillary plexus, VD Vascular density, CFD Choriocapillaris flow density.
*Statistically significant p value. a Spearman correlation analysis.
|
Table 4
Multiple linear regression analysis of related factors was conducted CFD as dependent variables.
|
CFD1.0
|
|
CFD1.5
|
|
CFD3.0
|
|
|
β
|
p value
|
β
|
p value
|
β
|
p value
|
Age
|
-0.021
|
0.902
|
0.042
|
0.807
|
0.093
|
0.619
|
BCVA
|
0.030
|
0.825
|
0.065
|
0.629
|
0.086
|
0.562
|
FAZ
|
-0.494
|
0.015*
|
-0.527
|
0.009*
|
-0.566
|
0.010*
|
CMT
|
-0.322
|
0.026*
|
-0.466
|
0.002*
|
-0.342
|
0.028*
|
SFCT
|
-0.182
|
0.215
|
-0.131
|
0.364
|
-0.070
|
0.654
|
SCP VD
|
0.102
|
0.462
|
0.181
|
0.191
|
0.064
|
0.667
|
DCP VD
|
0.277
|
0.047*
|
0.275
|
0.045*
|
0.283
|
0.059
|
logMAR Logarithm of the minimal angle of resolution, BCVA Best-corrected visual acuity, FAZ Foveal avascular zone, CMT Central macular thickness, SFCT Subfoveal choroidal thickness, SCP Superficial capillary plexus, DCP Deep capillary plexus, VD Vascular density, CFD Choriocapillaris flow density.
*Statistically significant p value.
|